#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11168	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2015	547.2	0	.	n	.	0	C451T	SNP	451	451	C	686	686	T	579	T,C	416,146	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11168	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2015	547.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1419	1419	C	643	C	622	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11168	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2015	547.2	0	HET	.	.	.	C207T	.	207	207	C	442	442	C	631	C,T	452,141	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21266	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3549	595.6	0	.	n	.	0	T695C	SNP	695	695	T	1023	1023	C	652	C	630	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21266	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3549	595.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2299	2299	C	647	C	620	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21266	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3549	595.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2373	2373	A	624	A	609	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21266	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3549	595.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2925	2925	C	643	C	619	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21266	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3549	595.6	0	HET	.	.	.	A1638G,T	.	1638	1638	A	1966	1966	A	681	A,G,T	511,140,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1228	folP	855	855	100.0	folP.l15.c4.ctg.1	1458	83.6	1	SNP	p	R229S	1	.	.	685	687	AGC	940	942	AGC	125;125;125	A;G;C	121;121;122	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3596	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3286	108.7	1	SNP	p	S91F	1	.	.	271	273	TTC	532	534	TTC	125;124;124	T;T;C	123;121;120	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3596	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3286	108.7	1	SNP	p	G95N	0	.	.	283	285	GGC	544	546	GGC	119;118;115	G;G,C;C	116;114,1;113	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3596	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3286	108.7	1	SNP	p	D95G	1	.	.	283	285	GGC	544	546	GGC	119;118;115	G;G,C;C	116;114,1;113	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1148	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1326	86.2	1	SNP	p	G45D	0	.	.	133	135	GGC	493	495	GGC	157;158;159	G;G;C,T	154;153;154,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	600	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	992	60.0	0	.	n	.	0	A197.	DEL	197	197	A	598	598	A	149	A	141	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3930	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2906	134.4	1	SNP	p	D86N	0	.	.	256	258	GAC	522	524	GAC	166;166;168	G;A,G;C	163;153,1;162	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3930	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2906	134.4	1	SNP	p	R87W	0	.	.	259	261	CGT	525	527	CGT	169;171;171	C;G,T;T	165;164,1;159	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3930	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2906	134.4	1	SNP	p	S87R	1	.	.	259	261	CGT	525	527	CGT	169;171;171	C;G,T;T	165;164,1;159	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3930	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2906	134.4	1	SNP	p	R87I	0	.	.	259	261	CGT	525	527	CGT	169;171;171	C;G,T;T	165;164,1;159	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3930	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2906	134.4	1	SNP	p	S88P	0	.	.	262	264	TCC	528	530	TCC	171;171;173	T;C;C	164;162;166	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2754	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2616	104.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1498	1500	GGC	134;132;132	G;G;C	129;125;127	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2499	111.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1327	1329	GCC	184;182;185	G;C,T;C,A	174;173,1;174,2	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2499	111.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1330	1332	ATG	185;185;183	A;T;G,C	177;176;174,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2499	111.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1342	1344	ACC	178;178;183	A;C;C,G	165;171;174,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2499	111.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1342	1344	ACC	178;178;183	A;C;C,G	165;171;174,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2499	111.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1843	1845	ACC	141;142;142	A;C;C,T	128;134;132,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2499	111.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1897	1899	GCG	144;145;144	G;C;G	138;136;137	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2499	111.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1897	1899	GCG	144;145;144	G;C;G	138;136;137	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2499	111.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2020	2022	GGT	95;96;94	G;G;T	91;91;89	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2499	111.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2029	2031	AGC	92;92;93	A;G;C,G	87;87;87,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2834	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2499	111.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2047	2049	CCG	76;78;79	C,G;C,G;G	62,3;66,2;62	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4372	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3140	138.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1691	1693	CCG	162;164;165	C;C;G,A	152;155;149,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1810	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1749	102.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	571	571	C	117	C	112	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2202	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1570	138.9	0	.	p	.	0	G210R	NONSYN	628	630	GGA	947	949	AGA	180;177;171	A,G;G;A	170,4;165;166	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2202	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1570	138.9	0	.	p	.	0	S217G	NONSYN	649	651	AGT	968	970	GGT	180;179;180	G,A;G;T	165,5;172;171	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2202	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1570	138.9	1	SNP	p	G120K	1	.	.	358	360	AAG	677	679	AAG	186;185;184	A;A;G	180;179;166	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2202	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1570	138.9	1	SNP	p	A121N	1	.	.	361	363	AAC	680	682	AAC	186;187;187	A,G;A;C,A	174,3;180;176,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2202	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1570	138.9	1	SNP	p	N121D	0	.	.	361	363	AAC	680	682	AAC	186;187;187	A,G;A;C,A	174,3;180;176,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7932	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4814	163.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	874	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	977	89.0	1	SNP	p	V57M	1	.	.	169	171	ATG	504	506	ATG	183;186;185	A;T;G	178;181;177	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
